๐ข Recruiting
Phase 1
๐ Investigational Drug / Biologic
NCT05394103
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
๐ Mayo Clinic โ Phoenix, Arizona
View Study & Checklist โ